Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $27.22. The company's market cap stands at 154.75B, with a P/E ratio of 19.99 and a dividend yield of 6.3%.
During the trading session on 2026-04-08, Pfizer(PFE) shares reached a daily high of $27.50 and a low of $26.97. At a current price of $27.22, the stock is +0.9% higher than the low and still -1.0% under the high.
Trading volume for Pfizer(PFE) stock has reached 16.63M, versus its average volume of 36.96M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $20.92.
PFE News
Belgian court orders Poland and Romania to honor multi billion euro COVID 19 vaccine contracts with Pfizer/BioNTech. Ruling requires the countries to take deli...
On the second trading day of the week, Pfizer (PFE 2.62%) was a laggard on the stock exchange. An analyst reiterated his bearish view of the stock, and more tha...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Analyst ratings
55%
of 29 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Key Points Pfizer's declining revenue and questions about its growth have weighed down the stock in recent years. The company, however, has been bolstering it...
High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout By Vandita Jadeja Published Apr 6, 12:15PM EDT Quick Read Abb...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. End of Quarter Sale - 50% Off TipRanks Unlock hedge...
Pfizer and Valneva recently reported that their investigational 6‑valent OspA-based Lyme disease vaccine achieved more than 70% efficacy in a completed Phase 3...
England’s National Health Service announced on Thursday that three million more older adults in the country will be eligible to receive Pfizer’s (PFE) respirato...
Pfizer is closing its South San Francisco research site and office and shifting affected roles to remote work. The move is part of a broader cost cutting effor...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.